Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

Market Closed
8 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
40. 08
+0.92
+2.35%
$
1.75B Market Cap
35.95 P/E Ratio
0.48% Div Yield
273,848 Volume
1.1 Eps
$ 39.16
Previous Close
Day Range
39.12 40.79
Year Range
16.16 46.42
Want to track PAHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 56 days
PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

Phibro successfully acquires Zoetis Inc.'s MFA portfolio and certain water-soluble products.

Zacks | 1 year ago
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Finding Great Top-Ranked Momentum Stocks to Buy Now

Finding Great Top-Ranked Momentum Stocks to Buy Now

The stocks we learn to search for today are top-ranked momentum stocks that might be worth buying to close out October and throughout the last two months of 2024.

Zacks | 1 year ago
PAHC vs. PODD: Which Stock Is the Better Value Option?

PAHC vs. PODD: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
New Animal Health Products, Vaccine Sales Support PAHC Stock

New Animal Health Products, Vaccine Sales Support PAHC Stock

Phibro Animal Health is focusing on new developments, incremental registrations and volumes of existing vaccine technologies.

Zacks | 1 year ago
PAHC or ABT: Which Is the Better Value Stock Right Now?

PAHC or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?

Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
PAHC vs. ABT: Which Stock Is the Better Value Option?

PAHC vs. ABT: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
Is Phibro Stock Worth Retaining in Your Portfolio Now?

Is Phibro Stock Worth Retaining in Your Portfolio Now?

PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.

Zacks | 1 year ago
Loading...
Load More